06:50 AM EDT, 03/22/2024 (MT Newswires) -- ProKidney ( PROK ) reported a 2023 net loss late Thursday of $0.57 per diluted share, wider than the loss of $0.23 a year earlier.
Two analysts polled by Capital IQ expected a loss of $0.65.
The company did not report any revenue for the quarter ended Dec. 31, as expected.
The company said it had cash and cash equivalents of $60.6 million at year-end 2023.